Telix Pharmaceuticals Limited financial statements, including revenue, expenses, and profit

The total revenue of A2H7JK for the last semiannual is 250.55 M EUR, and it's 10.61% higher compared to the previous semiannual. The net income of H2 24 is 12.11 M EUR.